Related Experiment Video
Updated: Aug 13, 2025
Protocol for Recombinant RBD-based SARS Vaccines: Protein Preparation, Animal Vaccination and Neutralization Detection
Published on: May 2, 2011
Recombinant Protein Vaccines against Human Betacoronaviruses: Strategies, Approaches and Progress
Angelina Kovalenko1, Ekaterina Ryabchevskaya1, Ekaterina Evtushenko1
1Department of Virology, Faculty of Biology, Lomonosov Moscow State University, 119234 Moscow, Russia.
Abstract:
Betacoronaviruses have already troubled humanity more than once. In 2002-2003 and 2012, the SARS-CoV and MERS-CoV, respectively, caused outbreaks of respiratory syndromes with a fatal outcome. The spread of the SARS-CoV-2 coronavirus has become a pandemic. These three coronaviruses belong to the genus Betacoronavirus and have a zoonotic origin. The emergence of new coronavirus infections in the future cannot be ruled out, and vaccination is the main way to prevent the spread of the infection. Previous experience in the development of vaccines against SARS and MERS has helped to develop a number of vaccines against SARS-CoV-2 in a fairly short time. Among them, there are quite a few recombinant protein vaccines, which seem to be very promising in terms of safety, minimization of side effects, storage and transportation conditions. The problem of developing a universal betacoronavirus vaccine is also still relevant. Here, we summarize the information on the designing of vaccines based on recombinant proteins against highly pathogenic human betacoronaviruses SARS-CoV, MERS-CoV and SARS-CoV-2.
Insights
Recombinant protein vaccines offer a promising, safe, and stable approach to combatting betacoronaviruses like SARS-CoV, MERS-CoV, and SARS-CoV-2. Developing a universal betacoronavirus vaccine remains a critical goal for future pandemic prevention.
Area of Science:
- Virology and Immunology
- Vaccine Development
- Infectious Diseases
Background:
- Betacoronaviruses, including SARS-CoV, MERS-CoV, and SARS-CoV-2, are zoonotic viruses responsible for severe respiratory illnesses and pandemics.
- Previous outbreaks highlight the ongoing threat of novel betacoronaviruses and the critical need for effective vaccines.
- The development of vaccines against SARS-CoV-2 benefited from prior experience with SARS and MERS vaccine research.
Purpose of the Study:
- To review the design of recombinant protein vaccines against highly pathogenic human betacoronaviruses.
- To highlight the potential of recombinant protein vaccine technology for current and future betacoronavirus threats.
- To discuss the relevance of developing a universal betacoronavirus vaccine.
Main Methods:
- Literature review and summarization of existing research on recombinant protein vaccine design.
- Analysis of vaccine strategies targeting the spike proteins of SARS-CoV, MERS-CoV, and SARS-CoV-2.
- Evaluation of the advantages of recombinant protein vaccines, including safety, efficacy, and logistical considerations.
Main Results:
- Recombinant protein vaccines have emerged as a significant and promising platform for combating betacoronavirus infections.
- These vaccines demonstrate potential for enhanced safety profiles and improved storage and transportation conditions compared to other vaccine types.
- Previous vaccine development efforts for SARS and MERS provided a foundation for the rapid advancement of SARS-CoV-2 vaccines.
Conclusions:
- Recombinant protein vaccines represent a viable and advantageous strategy for addressing SARS-CoV, MERS-CoV, and SARS-CoV-2.
- Continued research into universal betacoronavirus vaccines is essential for preparedness against future zoonotic spillover events.
- The safety, stability, and efficacy of recombinant protein vaccines make them a key focus for current and future infectious disease control.
Related Concept Videos
01:09Recombinant DNA
02:50Conjugated Proteins
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...